glp-1 receptor agonist dry eye Agonists and vision risk Glucagon-Like Peptide 1 Receptor Agonists

To examine this effect, four trials were designed to evaluate Saxendas efficacy in obesity management

Further, GLP-1RAs block the adhesion of monocytes to endothelium induced by oxidized LDL via extracellular signal-regulated kinase (ERK) 5-Kruppel-like factor (KLF)2 signaling pathway to prevent endothelial permeability [107, 108]

doi: 10.1016/j.molmet.2018.09.009 [DOI] [PMC free article] [PubMed] [Google Scholar] 75.Furihata K, Mimura H, Urva S, Oura T, Ohwaki K, Imaoka T

Parkman HP, Van Natta ML, Abell TL, et al

GLP-1 drugs may target an earlier step in the drug attachment, addiction, and relapse cycle

Surprisingly, a growing number of clinical studies demonstrate that these drugs (and other GLP-1 RAs) may have benefits that extend far beyond their original purpose, with their effects spanning the heart, kidneys, liver, and more